NCIt definition : A fully human monoclonal agonistic antibody directed against tumor necrosis factor-alpha
(TNF-alpha)-related apoptosis-inducing ligand receptor-2 (TRAIL-R2) with potential
antitumor activity. Mimicking the natural ligand TRAIL, lexatumumab binds to and activates
TRAIL-R2, which may trigger apoptosis in and inhibit the growth of TRAIL-R2-expressing
tumor cells. TRAIL-R2, also known as death receptor 5 (DR5), is a member of the TNF
receptor family and is expressed on many malignant cell types.;
Alternative definition : NCI-GLOSS: A substance being studied in the treatment of some types of cancer. It
binds to a protein called TRAIL-R2 on the surface of some tumor cells, which may kill
the tumor cells. HGS-ETR2 is a type of monoclonal antibody.;
UNII : 967Q0SJD77;
CAS number : 845816-02-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 845816-02-6
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;
Molecule name : HGS-ETR2; HGS1018;
Codes from synonyms : CDR0000537263; CDR0000641121; CDR0000643597;